Your SlideShare is downloading. ×
Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

135
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
135
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Contraceptives Market to 2018 - Safety Concerns PlagueDrospirenone-containing Birth Control Pills and Long-term Useof EstrogenReport Details:Published:November 2012No. of Pages: 85Price: Single User License – US$3500Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth ControlPills and Long-term Use of EstrogenSummaryGBI Research, a leading business intelligence provider, has released its latest research,“Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth ControlPills and Long-term Use of Estrogen”, which provides insights into the global contraceptivesmarket and market forecasts until 2018. The report provides an in-depth analysis of the mostcommonly used contraceptives, such as oral, topical, and injectable contraceptives, and devicessuch as intrauterine devices, condoms, and vaginal rings. The report also examines the usagepatterns and annual cost of usage for these segments. It also includes insights into thecontraceptives R&D product pipeline and explores the competitive landscape, including majorcompanies in the contraceptives market. Finally, the report also includes analysis of the mergersand acquisitions (M&A) and licensing agreements that have taken place in the globalcontraceptives market.The contraceptives market is growing, and more than 90 million people from seven major marketsused them in 2011, with more than 24 million people having used them in the US alone. The userpopulation is expected to grow gradually during the forecast period and reach more than 94 millionin 2018.According to GBI Research’s analysis, in 2011, the contraceptives market was worth $10.2 billion,indicating a Compounded Annual Growth Rate (CAGR) of 2.7% between 2004 and 2011. By2018, the market is expected to reach $11.8 billion, growing at a CAGR of 2.1%. The launch of theFC patch, AG200-15, Savvy Gel, LNG 20, Pill-Plus and some key products in the late stagepipeline combined with increasing awareness are expected to drive the market.
  • 2. The annual cost of usage for contraceptives was $113 in 2011, which grew from $104 in 2004 at aCAGR of 1.2%. This is expected to grow to $125 in 2018, at a CAGR of 1.4% between 2011 and2018. The growth rate can be attributed to factors such as the expected patent expiry of Mirenaand Yaz. In the forecast period, CSD500, a condom manufactured by Futura Medical and licensedto Reckitt and Benckiser, is expected to strengthen the condom market.The report is built using data and information sourced from proprietary databases, primary andsecondary research, and in-house analysis by GBI Research’s team of industry experts.Scope- Data and analysis on the contraceptives market in leading geographies: the US, the UK,Germany, France, Italy, Spain and Japan; along with their reach in emerging markets.- Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives,condoms, intrauterine devices and vaginal rings in the contraceptives market from 2004–2011,with forecasts to 2018.- Market data on the therapeutic landscape, which covers oral, topical and injectablecontraceptives, and includes market revenues, treatment usage patterns and the annual cost ofusage.- Key drivers and restraints that have had a significant impact on the market.- The competitive landscape of the contraceptives market, which includes companies such asBayer, Merck, Church & Dwight, Warner Chilcott Company, and Pfizer.- Key M&A activities and licensing agreements that took place from 2008–2012 in thecontraceptives market.Reasons to buy- Align your product portfolio to markets with high growth potential.- Develop market-entry and market expansion strategies by identifying the potential region andtherapeutic segments poised for strong growth.- Devise a more specifically-tailored country strategy through understanding of the key drivers andbarriers in the contraceptives market of all the major countries.- Develop key strategic initiatives by understanding the key focus areas of leading companies.- Accelerate and strengthen your market position by identifying key companies for mergers,acquisitions and strategic partnerships.Get your copy of this report @http://www.reportsnreports.com/reports/206063-contraceptives-market-to-2018-safety-concerns-plague-drospirenone-containing-birth-control-pills-and-long-term-use-of-estrogen.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 5
  • 3. 1.1 List of Tables 71.2 List of Figures 92 Contraceptives Market to 2018 - Introduction 103 Contraceptives Market to 2018 - Market Overview 123.1 Introduction 123.2 Revenue Forecasts for Contraceptives Market 123.2.1 Revenues 123.2.2 Annual Cost of Usage for Contraceptives 153.2.3 Contraceptive Users 163.3 Drivers and Barriers for the Contraceptives Market 173.3.1 Drivers for Contraceptives Therapeutics Market 173.3.2 Barriers for Contraceptives 184 Contraceptives Market to 2018 - Geographical Landscape 194.1 The US 194.1.1 Revenue 194.1.2 Annual Cost of Usage for Contraceptives 204.1.3 Contraceptive Users 214.2 Top Five Countries of Europe 224.2.1 Revenue 224.2.2 Annual Cost of Usage for Contraceptives 234.2.3 Contraceptive Users 244.3 Japan 254.3.1 Revenue 254.3.2 Annual Cost of Usage for Contraceptives 264.3.3 Contraceptive Users 275 Contraceptives Market to 2018 - Therapeutic Landscape 285.1 Oral Contraceptives 285.1.1 Introduction 285.1.2 Combined Hormonal Contraception 295.1.3 Oral Contraceptive Historic Trends 295.1.4 Recently Approved Combined Oral Contraceptives 295.1.5 Revenue 305.1.6 Annual Cost of Usage 335.1.7 Oral Contraceptive Users 345.2 Injectables 355.2.1 Introduction 355.2.2 Revenue 355.2.3 Annual Cost of Usage 395.2.4 Injectable Contraceptive Users 405.3 Topical Contraceptives 415.3.1 Introduction 415.3.2 Revenue 42
  • 4. 5.3.3 Annual Cost of Usage 455.3.4 Topical Contraceptive Users 466 Contraceptives Market to 2018 - Devices Landscape 476.1 Vaginal Ring 476.1.1 Introduction 476.1.2 Revenue 476.1.3 Geographical Segmentation 496.1.4 Annual Cost of Usage 516.1.5 Vaginal Ring Users 526.2 Intrauterine Device 536.2.1 Introduction 536.2.2 Revenue 536.2.3 Geographical Segmentation 556.2.4 Annual Cost of Usage 576.2.5 IUDs Users 586.3 Condoms 596.3.1 Introduction 596.3.2 Revenue 596.3.3 Geographical Segmentation 606.3.4 Annual Cost of Usage 626.3.5 Condom Users 637 Emerging Markets 647.1 China 647.2 Australia 657.3 India 668 Contraceptives Market to 2018 - Pipeline Analysis 678.1 Introduction 678.2 Profiles of Promising Drugs in the Global Contraceptives Market 688.2.1 AG200-15 688.2.2 FC Patch Low 688.2.3 Pill-Plus 699 Contraceptives Market to 2018 - Competitive Landscape 709.1 Market Share Analysis - Contraceptives Market 709.2 Drug Profile of Major Marketed Contraceptives 719.2.1 Yaz/Yasmin 719.2.2 Mirena 719.2.3 Nuvaring 719.3 Competitive Profiling 729.3.1 Bayer 729.3.2 Merck 739.3.3 Church & Dwight 749.3.4 Warner Chilcott Company, Inc. 75
  • 5. 9.3.5 Pfizer Inc. 7610 Contraceptives Market to 2018 - Strategic Consolidations 7710.1 Mergers and Acquisitions 7710.1.1 Major M&A Deals 7710.1.2 Licensing Agreements 7710.1.3 Deals by Geography 7810.1.4 Major Licensing Agreements 7810.1.5 Co-development 7911 Contraceptives Market to 2018 - Appendix 8011.1 Market Definitions 8011.2 Abbreviations 8011.3 Bibliography 8011.4 Research Methodology 8111.4.1 Coverage 8211.4.2 Secondary Research 8211.4.3 Primary Research 8211.4.4 Expert Panel Validation 8311.5 Therapeutic Landscape 8311.5.1 Epidemiology-Based Forecasting 8311.5.2 Market Size by Geography 8411.6 Geographical Landscape 8411.7 Pipeline Analysis 8411.8 Competitive Landscape 8411.9 Contact Us 8511.10 Disclaimer 851.1 List of TablesTable 1: Contraceptives Market, Global, Revenue ($bn), 2004-2011 12Table 2: Contraceptives Market, Global, Revenue Forecasts ($bn), 2011-2018 12Table 3: Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-201113Table 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2011-2018 14Table 5: Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 15Table 6: Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 15Table 7: Contraceptives Market, Global, Contraceptive Users (Million), 2004-2011 16Table 8: Contraceptives Market, Global, Contraceptive Users (Million), 2011-2018 16Table 9: Contraceptives Market, The US, Revenue ($bn), 2004-2011 19Table 10: Contraceptives Market, The US, Revenue Forecasts ($bn), 2011-2018 19Table 11: Contraceptives Market, The US, Annual Cost of Usage ($), 2004-2011 20Table 12: Contraceptives Market, The US, Annual Cost of Usage ($), 2011-2018 20Table 13: Contraceptives Market, The US, Contraceptive Users (Million), 2004-2011 21
  • 6. Table 14: Contraceptives Market, The US, Contraceptive Users (Million), 2011-2018 21Table 15: Contraceptives Market, Top Five Countries of Europe, Revenue ($m), 2004-2011 22Table 16: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2011-2018 22Table 17: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2004-2011 23Table 18: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2011-2018 23Table 19: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million),2004-2011 24Table 20: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million),2011-2018 24Table 21: Contraceptives Market, Japan, Revenue ($m), 2004-2011 25Table 22: Contraceptives Market, Japan, Revenue Forecasts ($m), 2011-2018 25Table 23: Contraceptives Market, Japan, Annual Cost of Usage ($), 2004-2011 26Table 24: Contraceptives Market, Japan, Annual Cost of Usage ($), 2011-2018 26Table 25: Contraceptives Market, Japan, Contraceptive Users (Million), 2004-2011 27Table 26: Contraceptives Market, Japan, Contraceptive Users (Million), 2011-2018 27Table 27: Oral Contraceptives Market, Global, Revenue ($bn), 2004-2011 30Table 28: Oral Contraceptives Market, Global, Revenue Forecasts ($bn), 2011-2018 30Table 29: Oral Contraceptives Market, Global, Revenue by Geographical Segmentation ($m),2004-2011 31Table 30: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation($m), 2011-2018 32Table 31: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 33Table 32: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 33Table 33: Oral Contraceptives Market, Global, Users (Million), 2004-2011 34Table 34: Oral Contraceptives Market, Global, Users (Million), 2011-2018 34Table 35: Injectables Market, Global, Revenue ($m), 2004-2011 36Table 36: Injectables Market, Global, Revenue Forecasts ($m), 2011-2018 36Table 37: Injectables Market, Global, Revenue by Geographical Segmentation ($m), 2004-201137Table 38: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2011-2018 38Table 39: Injectables Market, Global, Annual Cost of Usage ($), 2004-2011 39Table 40: Injectables Market, Global, Annual Cost of Usage ($), 2011-2018 39Table 41: Injectable Contraceptives Market, Global, Users (‘000), 2004-2011 40Table 42: Injectable Contraceptives Market, Global, Users (‘000), 2011-2018 40Table 43: Topical Contraceptives Market, Global, Revenue ($m), 2004-2011 42Table 44: Topical Contraceptives Market, Global, Revenue Forecasts ($m), 2011-2018 42Table 45: Topical Contraceptives Market, Global, Revenue by Geographical Segmentation ($m),2004-2011 43
  • 7. Table 46: Topical Contraceptives Market, Global, Revenue Forecasts by GeographicalSegmentation ($m), 2011-2018 44Table 47: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 45Table 48: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 45Table 49: Topical Contraceptives Market, Global, Users (Million), 2004-2011 46Table 50: Topical Contraceptives Market, Global, Users (Million), 2011-2018 46Table 51: Vaginal Ring Market, Global, Revenue ($m), 2004-2011 48Table 52: Vaginal Ring Market, Global, Revenue Forecasts ($m), 2011-2018 48Table 53: Vaginal Ring Market, Global, Revenue by Geographical Segmentation ($m), 2004-201149Table 54: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2011-2018 50Table 55: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2004-2011 51Table 56: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2011-2018 51Table 57: Vaginal Ring Market, Global, Users (’000), 2004-2011 52Table 58: Vaginal Ring Market, Global, Users (‘000), 2011-2018 52Table 59: Intrauterine Devices Market, Global, Revenue ($m), 2004-2011 54Table 60: Intrauterine Device Market, Global, Revenue Forecasts ($m), 2011-2018 54Table 61: IUDs Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 55Table 62: IUDs Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 56Table 63: IUDs Market, Global, Annual Cost of Usage ($), 2004-2011 57Table 64: IUDs Market, Global, Annual Cost of Usage ($), 2011-2018 57Table 65: IUDs Market, Global, Users (Million), 2004-2011 58Table 66: IUDs Market, Global, Users (Million), 2011-2018 58Table 67: Condoms Market, Global, Revenue ($bn), 2004-2011 59Table 68: Condoms Market, Global, Revenue Forecasts ($bn), 2011-2018 59Table 69: Condoms Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 60Table 70: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2011-2018 61Table 71: Condoms Market, Global, Annual Cost of Usage ($), 2004-2011 62Table 72: Condoms Market, Global, Annual Cost of Usage ($), 2011-2018 62Table 73: Condom Market, Global, Users (Million), 2004-2011 63Table 74: Condom Market, Global, Users (Million), 2011-2018 63Table 75: Contraceptives Market, Method of Contraceptive Used (%), China 64Table 76: Contraceptives Market, Method of Contraceptive Used (%), Australia 65Table 77: Contraceptives Market, Method of Contraceptive Usage (%), India 66Table 78: Contraceptives Market, Global, Product Pipeline by Phase, 2012 67Table 79: Contraceptives Market, Global, Revenues of Major Marketed Contraceptives ($m), 2011711.2 List of Figures
  • 8. Figure 1: Contraceptives Market, Global, Revenue Forecasts ($bn), 2004-2018 12Figure 2: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2004-2018 13Figure 3: Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 15Figure 4: Contraceptives Market, Global, Contraceptive Users (Million), 2004-2018 16Figure 5: Contraceptives Market, Global, Drivers and Barriers, 2011 17Figure 6: Contraceptives Market, The US, Revenue Forecasts ($bn), 2004-2018 19Figure 7: Contraceptives Market, The US, Annual Cost of Usage ($), 2004-2018 20Figure 8: Contraceptives Market, The US, Contraceptive Users (Million), 2004-2018 21Figure 9: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2004-2018 22Figure 10: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2004-2018 23Figure 11: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million),2004-2018 24Figure 12: Contraceptives Market, Japan, Revenue Forecasts ($m), 2004-2018 25Figure 13: Contraceptives Market, Japan, Annual Cost of Usage ($), 2004-2018 26Figure 14: Contraceptives Market, Japan, Contraceptive Users (Million), 2004-2018 27Figure 15: Oral Contraceptives Market, Global, Revenue Forecasts ($bn), 2004-2018 30Figure 16: Oral Contraceptives Market, Global, Revenue Forecasts by GeographicalSegmentation ($m), 2004-2018 31Figure 17: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 33Figure 18: Oral Contraceptives Market, Global, Users (Million), 2004-2018 34Figure 19: Injectables Market, Global, Revenue Forecasts ($m), 2004-2018 35Figure 20: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2004-2018 37Figure 21: Injectables Market, Global, Annual Cost of Usage ($), 2004-2018 39Figure 22: Injectable Contraceptives Market, Global, Users (‘000), 2004-2018 40Figure 23: Topical Contraceptives Market, Global, Revenue Forecasts ($m), 2004-2018 42Figure 24: Topical Contraceptives Market, Global, Revenue Forecasts by GeographicalSegmentation ($m), 2004-2018 43Figure 25: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 45Figure 26: Topical Contraceptives Market, Global, Users (Million), 2004-2018 46Figure 27: Vaginal Ring Market, Global, Revenue Forecasts ($m), 2004-2018 47Figure 28: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2004-2018 49Figure 29: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2004-2018 51Figure 30: Vaginal Ring Market, Global, Users (‘000), 2004-2018 52Figure 31: Intrauterine Devices Market, Global, Revenue Forecasts ($m), 2004-2018 53Figure 32: IUDs Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 55Figure 33: IUDs Market, Global, Annual Cost of Usage ($), 2004-2018 57
  • 9. Figure 34: IUDs Market, Global, Users (Million), 2004-2018 58Figure 35: Condoms Market, Global, Revenue Forecasts ($bn), 2004-2018 59Figure 36: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation ($m),2004-2018 60Figure 37: Condoms Market, Global, Annual Cost of Usage ($), 2004-2018 62Figure 38: Condom Market, Global, Users (Million), 2004-2018 63Figure 39: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011 67Figure 40: Contraceptives Market, Global, Market Share Analysis, (%), 2011 70Figure 41: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011 72Figure 42: Contraceptives Market, Global, Merck, SWOT Analysis, 2011 73Figure 43: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011 74Figure 44: Contraceptives Market, Global, Warner Chilcott Company, Inc., SWOT Analysis, 201175Figure 45: Contraceptives Market, Global, Pfizer Inc., SWOT Analysis, 2011 76Figure 46: Contraceptives Market, Global, Licensing Agreements by Geography, 2011 78Contact: sales@reportsandreports.com for more information.